Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus
December 2016
Look for Basaglar (BAY-zuh-glar) to replace Lantus on home med lists...as some insurers drop Lantus from their formularies in 2017.
Basaglar is a new brand of glargine U-100...NOT a Lantus generic.
Whether Basaglar makes its way to your hospital formulary may depend on whether your hospital stocks insulin pens...since Basaglar is only available as a KwikPen device.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote